Mr Anthony Paronneau > McDermott Will & Emery AARPI > Paris, France > Lawyer Profile

McDermott Will & Emery AARPI
23 RUE DE L'UNIVERSITÉ
75007 PARIS
France
Anthony Paronneau photo

Work Department

Corporate & Transactional / Life Sciences

Position

Anthony Paronneau is a partner, he advises clients on all aspects of corporate and business law, with a particular focus on pharmaceutical, medical device, biotech and health care industries. Anthony has significant experience advising life sciences companies, private equity funds and venture capital firms on a number of merger and acquisition (M&A) and private equity transactions, including acquisitions, financing rounds, joint ventures and divestitures. He also regularly advises life sciences companies on collaborations, licensing and distribution arrangements.

For further details of Anthony’s biography, please view McDermott website here.

Languages

English
French
Italian

Memberships

Admitted to the Paris Bar

Education

HEC Paris School of Management, Graduate, DMI-04
Université Paris – Sud 11, DEA, Private Law, 2003
Université Paris – Sud 11, Maîtrise, Business Law, 2001

Lawyer Rankings

France > Industry focus: Healthcare and life sciences

(Leading individuals)

Anthony ParonneauMcDermott Will & Emery AARPI

The ‘undeniably competent‘ team at McDermott Will & Emery AARPI stands out for its M&A and licencing work, advising key pharmaceutical manufacturers on strategic matters. At the forefront of science, the team handled the acquisition of SK Holdings on behalf of Yposkesi, the first French pharmaceutical manufacturer dedicated to the production of gene and cell therapy drugs for rare diseases. The team is led by Emmanuelle Trombe  and Anthony Paronneau, who are known for their ‘great legal skills as well as for an incomparable knowledge of the life sciences sector.’

Paris > Secteurs et industries > Santé et sciences de la vie

(Les grands avocats du marché)

Anthony ParonneauMcDermott Will & Emery AARPI

La «très compétente» équipe de McDermott Will & Emery AARPI est recommandée pour la qualité ses expertises en matière de fusions-acquisitions et de licensing. Le cabinet assiste de grands fabricants pharmaceutiques sur la gestion de leurs questions stratégiques. L’équipe a ainsi participé à l’acquisition de SK Holdings par son client Yposkesi (premier laboratoire pharmaceutique français dédié à la production de médicaments de thérapie génique et cellulaire pour les maladies rares). La pratique est codirigée par Emmanuelle Trombe  et  Anthony Paronneau, qui sont reconnus pour «leurs grandes compétences juridiques et leur connaissance incomparable du secteur des sciences de la vie ».